Suyi Li

机构：Yangtze University · ORCID：0000-0003-0581-0638

发表论文 105 篇 · 总被引 1536 次 · h-index 21

代表论文

• First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial (2023 · Nature Medicine · 被引 174)
• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 40)
• Modified black phosphorus quantum dots promotes spinal cord injury repair by targeting the AKT signaling pathway (2023 · Journal of Tissue Engineering · 被引 24)
• Diagnostic performance of GLIM and PG-SGA for malnutrition assessment in adult cancer patients: a systematic review and meta-analysis (2025 · BMC Cancer · 被引 16)
• The potential of machine learning models to identify malnutrition diagnosed by GLIM combined with NRS-2002 in colorectal cancer patients without weight loss information (2024 · Clinical Nutrition · 被引 16)
• Association of possible sarcopenia with all-cause mortality in patients with solid cancer: A nationwide multicenter cohort study (2024 · The journal of nutrition health & aging · 被引 11)